Trial of next-gen weight-loss drug retatrutide shows users lose almost a third of their body weight

While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors

Raccontata dahealio.comqz.comthehindubusinessline.comeu.usatoday.comzerohedge.comindependent.co.ukscientificamerican.comwashingtonexaminer.comtime.comeconomictimes.indiatimes.combenzinga.comtheverge.com+1 altre